758 related articles for article (PubMed ID: 19704306)
1. Public health issues related to HPV vaccination.
Hershey JH; Velez LF
J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
3. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
Saslow D; Wheeler CM
Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
Downs LS; Scarinci I; Einstein MH; Collins Y; Flowers L
Gynecol Oncol; 2010 Jun; 117(3):486-90. PubMed ID: 20303156
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus infection: an old disease, a new vaccine.
Giles M; Garland S
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
[TBL] [Abstract][Full Text] [Related]
7. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against HPV: indications for women and the impact on the cervical screening programme.
Heideman DA; Snijders PJ; Berkhof J; Verheijen RH; Helmerhorst TJ; Meijer CJ
BJOG; 2008 Jul; 115(8):938-46. PubMed ID: 18651878
[TBL] [Abstract][Full Text] [Related]
9. Understanding HPV disease and prevention: a guide for school nurses.
Lockwood-Rayermann S; McIntyre SJ
J Sch Nurs; 2009 Aug; 25(4):261-9. PubMed ID: 19363106
[TBL] [Abstract][Full Text] [Related]
10. Age considerations when vaccinating against HPV.
Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558
[TBL] [Abstract][Full Text] [Related]
11. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
Stanley M
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
[TBL] [Abstract][Full Text] [Related]
12. Decreasing risk: impact of HPV vaccination on outcomes.
Hymel PA
Am J Manag Care; 2006 Dec; 12(17 Suppl):S473-83. PubMed ID: 17203991
[TBL] [Abstract][Full Text] [Related]
13. [Vaccines against human papillomavirus (HPV); between registration and implementation].
van Rossum TG; de Melker HE; Houweling H; Voordouw AC; Meijer CJ; Helmerhorst TJ; Kretzschmar M; Berkhof J; van der Noordaa J
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):987-92. PubMed ID: 18549172
[TBL] [Abstract][Full Text] [Related]
14. The current and future role of screening in the era of HPV vaccination.
Myers E; Huh WK; Wright JD; Smith JS
Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
16. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the power of prevention: human papillomavirus vaccines.
Mayeaux EJ
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
[TBL] [Abstract][Full Text] [Related]
18. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
19. Initial lessons learned in HPV vaccination.
Herzog TJ; Huh WK; Downs LS; Smith JS; Monk BJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S4-11. PubMed ID: 18482557
[TBL] [Abstract][Full Text] [Related]
20. [Human papillomavirus vaccines].
Brun JL
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S155-66. PubMed ID: 18187268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]